Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

NCT00276796 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

NETWORK

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: cisplatin
DRUG: paclitaxel
DRUG: topotecan hydrochloride

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]